Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bioscience
BD Biosciences Launches BD UltraPool HLM 150 Reagent
June 24th, 2009
BD Biosciences, a segment of BD (Becton, Dickinson and Company), announced the launch of the BD UltraPool™ HLM 150 reagent that consists of human liver microsomes (HLM) for use in in vitro ADME (absorption, distribution, metabolism, and excretion) drug discovery screening and development. "BD Biosciences is committed to addressing the needs of pharmaceutical researchers," said Charles Crespi, Ph.D., Vice President of Discovery Biologicals, BD Biosciences. "This new reagent will allow scientists to maintain consistent, high-quality results in their assays and avoid the arduous task of qualifying new lots of reagents." Cytochromes P450 (CYPs) are...
Source: Vaccine Weekly (2009-06-24)
|
